Abeona Therapeutics (ABEO) Depreciation and Depletion (2012 - 2023)

Abeona Therapeutics (ABEO) recorded quarterly Depreciation and Depletion of $700000.0 in Q1 2023, down 12.5% quarter-over-quarter from $800000.0 in Q1 2022, and down 12.5% on a YoY basis from $800000.0 in Q1 2022.

Abeona Therapeutics (ABEO) Depreciation and Depletion (2012 - 2023) Analysis & Trends

Abeona Therapeutics' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $700000.0 for Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1,395.22
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Abeona Therapeutics 309.15 Mn 140.88 Mn 6.02 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 700,000.00
Mar 31, 2023 700,000.00
Mar 31, 2022 800,000.00
Mar 31, 2022 800,000.00
Dec 31, 2012 29,000.00
Dec 31, 2012 29,000.00